Results 11 to 20 of about 2,058,358 (352)

Treatment of Heart Failure with Preserved Ejection Fraction [PDF]

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2011
Heart failure contributes to more than 1 million hospitalizations annually and is one of the most common causes of repeat hospitalizations in the elderly. Previously, it was thought that mortality from heart failure with preserved ejection fraction (PEF) was lower than that from heart failure with reduced ejection fraction (REF), but more recent data ...
Barnes, Megan M., Dorsch, Michael P., Hummel, Scott L., Koelling, Todd M., Bleske, Barry E.   +4 more
openaire   +6 more sources

Treatment of heart failure with preserved ejection fraction

Monaldi Archives for Chest Disease, 2018
Heart failure, in its diverse forms based on the value of the ejection fraction, is associated to high mortality and the frequent need for hospitalization, with a consequent heavy burden on healthcare resources.
Alfredo Monteverde, Valeria Carlino, Giulia Ganci, Giuseppe Taormina, Mario Barbagallo   +4 more
doaj   +8 more sources

Heart Failure with Preserved Ejection Fraction [PDF]

Current Emergency and Hospital Medicine Reports, 2019
The incidence of heart failure with preserved ejection fraction (HFpEF] is rapidly increasing, yet many physicians may feel less knowledgeable about HFpEF when compared with heart failure with reduced ejection fraction (HFrEF]. The purpose of this review is to discuss the incidence, pathophysiology, clinical diagnosis, treatment, and prognosis of ...
Ryan, Abigalle
openaire   +4 more sources

Heart Failure With Preserved Ejection Fraction

Journal of geriatric cardiology : JGC, 2013
Progressive aging of the population and prolongation of life expectancy have led to the rising prevalence of heart failure (HF). Despite the improvements in medical therapy, the mortality rate of this condition has remained unacceptably high, becoming the primary cause of death in the elderly population.
Akshay S. Desai
openalex   +5 more sources

Heart failure with preserved ejection fraction [PDF]

Pflügers Archiv - European Journal of Physiology, 2014
Heart failure (HF) is a clinical syndrome of diverse etiologies and can be associated with preserved, reduced, or mid-range ejection fraction (EF). In the community, heart failure with preserved ejection fraction (HFpEF) is emerging as the most common form of HF.
Margaret M. Redfield, Wolfgang A. Linke, James D. Gladden   +2 more
  +15 more sources

Empagliflozin in Heart Failure with a Preserved Ejection Fraction [PDF]

New England Journal of Medicine, 2021
Sodium-glucose cotransporter 2 inhibitors reduce the risk of hospitalization for heart failure in patients with heart failure and a reduced ejection fraction, but their effects in patients with heart failure and a preserved ejection fraction are uncertain.In this double-blind trial, we randomly assigned 5988 patients with class II-IV heart failure and ...
Anker SD, Butler J, Filippatos G, Ferreira JP, Bocchi E, Böhm M, Brunner-La Rocca HP, Choi DJ, Chopra V, Chuquiure-Valenzuela E, Giannetti N, Gomez-Mesa JE, Janssens S, Januzzi JL, Gonzalez-Juanatey JR, Merkely B, Nicholls SJ, Perrone SV, Piña IL, Ponikowski P, Senni M, Sim D, Spinar J, Squire I, Taddei S, Tsutsui H, Verma S, Vinereanu D, Zhang J, Carson P, Lam CSP, Marx N, Zeller C, Sattar N, Jamal W, Schnaidt S, Schnee JM, Brueckmann M, Pocock SJ, Zannad F, Packer M, EMPEROR-Preserved Trial Investigators   +41 more
openaire   +6 more sources

Heart failure with preserved ejection fraction [PDF]

Clinical Medicine, 2018
Heart failure with preserved ejection fraction (HFpEF) represents a heterogeneous collection of conditions that are unified by the presence of a left ventricular ejection fraction ≥50%, evidence of impaired diastolic function and elevated natriuretic peptide levels, all within the context of typical heart failure signs and symptoms.
Harper, AR, Patel, HC, Lyon, AR
openaire   +6 more sources

Blood Immune Cell Alterations in Patients with Hypertensive Left Ventricular Hypertrophy and Heart Failure with Preserved Ejection Fraction

Journal of Cardiovascular Development and Disease, 2023
(1) Background: Chronic inflammation and fibrosis are key players in cardiac remodeling associated with left ventricular hypertrophy (LVH) and heart failure with a preserved ejection fraction (HFpEF). Monocytes and T-helpers (Th) are involved in both pro-
Artem Ovchinnikov, Anastasiya Filatova, Alexandra Potekhina, Tatiana Arefieva, Anna Gvozdeva, Fail Ageev, Evgeny Belyavskiy   +6 more
doaj   +1 more source

Diagnostic Value of Serum Concentration of Galectin-3 in Patients With Heart Failure With Preserved Ejection Fraction

Frontiers in Cardiovascular Medicine, 2022
BackgroundAlthough the predictive value of galectin-3 for heart failure with preserved ejection fraction has been demonstrated, the diagnostic value remains unclear.
Jing Jiang, Baojun Yang, Ying Sun, Jing Jin, Zhiying Zhao, Songming Chen   +5 more
doaj   +1 more source

Sex differences and atrial fibrillation in heart failure with reduced versus preserved ejection fraction [PDF]

, 2021
Heart failure is a major public health problem. Patients with heart failure often experience dyspnoea, fatigue and/or have peripheral oedema. The prognosis of heart failure remains poor, with a severely impaired quality of life, frequent hospitalizations
Santema, Bernadet
core   +1 more source